Page last updated: 2024-09-04

tariquidar and thiorphan

tariquidar has been researched along with thiorphan in 1 studies

Compound Research Comparison

Studies
(tariquidar)
Trials
(tariquidar)
Recent Studies (post-2010)
(tariquidar)
Studies
(thiorphan)
Trials
(thiorphan)
Recent Studies (post-2010) (thiorphan)
210161386655082

Protein Interaction Comparison

ProteinTaxonomytariquidar (IC50)thiorphan (IC50)
ThermolysinBacillus thermoproteolyticus9.5
NeprilysinRattus norvegicus (Norway rat)0.0058
NeprilysinOryctolagus cuniculus (rabbit)0.0085
NeprilysinHomo sapiens (human)0.0024
Angiotensin-converting enzyme Homo sapiens (human)0.2281
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.42
NeprilysinSus scrofa (pig)0.0062

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brimacombe, KR; Dulcey, AE; Goldsborough, AS; Gottesman, MM; Griffiths, G; Hall, MD; Handley, MD; Kannan, P; Pluchino, KM1

Other Studies

1 other study(ies) available for tariquidar and thiorphan

ArticleYear
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
    Journal of medicinal chemistry, 2011, Jul-28, Volume: 54, Issue:14

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Orphan Drug Production; Paclitaxel; RNA Stability; RNA, Messenger; Structure-Activity Relationship; Tiopronin

2011